Tags : LY-CoV1404

Clinical Trials

AbCellera to Initiate Clinical Trial of LY-CoV1404 Against Viral Variants

Shots: AbCellera reported that a second Ab from its collaboration with Lilly, LY-CoV1404 has entered clinical trials in patients with mild-to-moderate COVID-19. The program will join Lilly’s ongoing Blaze-4 study where it will be evaluated as monothx. and in combination with other mAbs AbCellera unveils the preclinical data demonstrating LY-CoV1404 binds to a rarely mutated […]Read More